Skip to main content
. 2010 Jun 2;3(6):1792–1811. doi: 10.3390/ph3061792

Figure 2.

Figure 2

FEV1 percentage of predicted values (A), FEV1/FVC ratio values (B), and FEF25%–75% values (C) in children with asthma (n = 14) at baseline (day -7), before treatment with montelukast (day 0), after treatment with oral montelukast (5 mg qd for four weeks) (day 28), and two weeks after montelukast withdrawal (day 42).